|
1
|
Horner MJ, Ries LAG, Krapcho M, Neyman N,
Aminou R, Howlader N, et al: SEER Cancer Statistics Review,
1975–2006. National Cancer Institute; Bethesda, MD: simpleseer.cancer.gov/csr/1975_2006/based on November
2008 SEER data submission, posted to the SEER web site, 2009.
Accessed on June 27, 2016.
|
|
2
|
CancerResearch UK: Oral cancer - UK
incidence statistics. https://.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/oral-cancer/incidenceAccessed
on. June 27–2016
|
|
3
|
Mashberg A, Boffetta P, Winkelman R and
Garfinkel L: Tobacco smoking, alcohol drinking, and cancer of the
oral cavity and oropharynx among U.S. veterans. Cancer.
72:1369–1375. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Myers JN, Elkins T, Roberts D and Byers
RM: Squamous cell carcinoma of the tongue in young adults:
Increasing incidence and factors that predict treatment outcomes.
Otolaryngol Head Neck Surg. 122:44–51. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Annertz K, Anderson H, Biörklund A, Möller
T, Kantola S, Mork J, Olsen JH and Wennerberg J: Incidence and
survival of squamous cell carcinoma of the tongue in Scandinavia,
with special reference to young adults. Int J Cancer. 101:95–99.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shiboski CH, Schmidt BL and Jordan RC:
Tongue and tonsil carcinoma: Increasing trends in the U.S.
population ages 20–44 years. Cancer. 103:1843–1849. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brown LM, Check DP and Devesa SS: Oral
cavity and pharynx cancer incidence trends by subsite in the United
States: Changing gender patterns. J Oncol. 2012:6494982012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Patel SC, Carpenter WR, Tyree S, Couch ME,
Weissler M, Hackman T, Hayes DN, Shores C and Chera BS: Increasing
incidence of oral tongue squamous cell carcinoma in young white
women, age 18 to 44 years. J Clin Oncol. 29:1488–1494. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mork J, Lie AK, Glattre E, Hallmans G,
Jellum E, Koskela P, Møller B, Pukkala E, Schiller JT, Youngman L,
et al: Human papillomavirus infection is a risk factor for
squamous-cell carcinoma of the head and neck. N Engl J Med.
344:1125–1131. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pintos J, Black MJ, Sadeghi N, Ghadirian
P, Zeitouni AG, Viscidi RP, Herrero R, Coutlée F and Franco EL:
Human papillomavirus infection and oral cancer: A case-control
study in Montreal, Canada. Oral Oncol. 44:242–250. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Garavello W, Spreafico R and Gaini RM:
Oral tongue cancer in young patients: A matched analysis. Oral
Oncol. 43:894–897. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Park JO, Sun DI, Cho KJ, Joo YH, Yoo HJ
and Kim MS: Clinical outcome of squamous cell carcinoma of the
tongue in young patients: A stage-matched comparative analysis.
Clin Exp Otorhinolaryngol. 3:161–165. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mallet Y, Avalos N, Le Ridant AM, Gangloff
P, Moriniere S, Rame JP, Poissonnet G, Makeieff M, Cosmidis A,
Babin E, et al: Head and neck cancer in young people: A series of
52 SCCs of the oral tongue in patients aged 35 years or less. Acta
Otolaryngol. 129:1503–1508. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hilly O, Shkedy Y, Hod R, Soudry E,
Mizrachi A, Hamzany Y, Bachar G and Shpitzer T: Carcinoma of the
oral tongue in patients younger than 30 years: Comparison with
patients older than 60 years. Oral Oncol. 49:987–990. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Friedlander PL, Schantz SP, Shaha AR, Yu G
and Shah JP: Squamous cell carcinoma of the tongue in young
patients: A matched-pair analysis. Head Neck. 20:363–368. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
SiegelmannDanieli N, Hanlon A, Ridge JA,
Padmore R, Fein DA and Langer CJ: Oral tongue cancer in patients
less than 45 years old: Institutional experience and comparison
with older patients. J Clin Oncol. 16:745–753. 1998.PubMed/NCBI
|
|
17
|
Pitman KT, Johnson JT, Wagner RL and Myers
EN: Cancer of the tongue in patients less than forty. Head Neck.
22:297–302. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Popovtzer A, Shpitzer T, Bahar G, Marshak
G, Ulanovski D and Feinmesser R: Squamous cell carcinoma of the
oral tongue in young patients. Laryngoscope. 114:915–917. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Davidson BJ, Root WA and Trock BJ: Age and
survival from squamous cell carcinoma of the oral tongue. Head
Neck. 23:273–279. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee CC, Ho HC, Chen HL, Hsiao SH, Hwang JH
and Hung SK: Squamous cell carcinoma of the oral tongue in young
patients: A matched-pair analysis. Acta Otolaryngol. 127:1214–1217.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Udeabor SE, Rana M, Wegener G, Gellrich NC
and Eckardt AM: Squamous cell carcinoma of the oral cavity and the
oropharynx in patients less than 40 years of age: A 20-year
analysis. Head Neck Oncol. 4:282012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chang KW, Liu CJ, Chu TH, Cheng HW, Hung
PS, Hu WY and Lin SC: Association between high miR-211 microRNA
expression and the poor prognosis of oral carcinoma. J Dent Res.
87:1063–1068. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tran N, O'Brien CJ, Clark J and Rose B:
Potential role of micro-RNAs in head and neck tumorigenesis. Head
Neck. 32:1099–1111. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP
and Wei WI: Mature miR-184 as potential oncogenic microRNA of
squamous cell carcinoma of tongue. Clin Cancer Res. 14:2588–2592.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kozaki K, Imoto I, Mogi S, Omura K and
Inazawa J: Exploration of tumor-suppressive microRNAs silenced by
DNA hypermethylation in oral cancer. Cancer Res. 68:2094–2105.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wong TS, Liu XB, Chung-Wai Ho A, Po-Wing
Yuen A, Wai-Man Ng R and Ignace Wei W: Identification of pyrovate
kinase type M2 as potential oncoprotein in squamous cell carcinoma
of tongue through microRNA profiling. Int J Cancer. 123:251–257.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hebert C, Norris K, Scheper MA, Nikitakis
N and Sauk JJ: High mobility group A2 is a target for miRNA-98 in
head and neck squamous cell carcinoma. Mol Cancer. 6:52007.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cui J, Li D, Zhang W, Shen L and Xu X:
Bioinformatics analyses combined microarray identify the
deregulated microRNAs in oral cancer. Oncol Lett. 8:218–222.
2014.PubMed/NCBI
|
|
29
|
Yang X, Wu H and Ling T: Suppressive
effect of microRNA-126 on oral squamous cell carcinoma in vitro.
Mol Med Rep. 10:125–130. 2014.PubMed/NCBI
|
|
30
|
Shi LJ, Zhang CY, Zhou ZT, Ma JY, Liu Y,
Bao ZX and Jiang WW: MicroRNA-155 in oral squamous cell carcinoma:
Overexpression, localization, and prognostic potential. Head Neck.
37:970–976. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li J, Huang H, Sun L, Yang M, Pan C, Chen
W, Wu D, Lin Z, Zeng C, Yao Y, et al: MiR-21 indicates poor
prognosis in tongue squamous cell carcinoma as an apoptosis
inhibitor. Clin Cancer Res. 15:3998–4008. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hedbäck N, Jensen DH, Specht L, Fiehn AM,
Therkildsen MH, Friis-Hansen L, Dabelsteen E and von Buchwald C:
MiR-21 expression in the tumor stroma of oral squamous cell
carcinoma: An independent biomarker of disease free survival. PLoS
One. 9:e951932014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kanno J, Aisaki KI, Igarashi K, Nakatsu N,
Ono A, Kodama Y and Nagao T: "Per cell" normalization method for
mRNA measurement by quantitative PCR and microarrays. BMC Genomics.
7:642006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang Y, Irish J, MacMillan C, Brown D,
Xuan Y, Boyington C, Gullane P and Kamel-Reid S: High frequency of
microsatellite instability in young patients with head-and-neck
squamous-cell carcinoma: Lack of involvement of the mismatch repair
genes hMLH1 AND hMSH2. Int J Cancer. 93:353–360. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
SantosSilva AR, Ribeiro AC, Soubhia AM,
Miyahara GI, Carlos R, Speight PM, Hunter KD, TorresRendon A,
Vargas PA and Lopes MA: High incidences of DNA ploidy abnormalities
in tongue squamous cell carcinoma of young patients: An
international collaborative study. Histopathology. 58:1127–1135.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Atula S, Grénman R, Laippala P and
Syrjänen S: Cancer of the tongue in patients younger than 40 years.
A distinct entity? Arch Otolaryngol Head Neck Surg. 122:1313–1319.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jin YT, Myers J, Tsai ST, Goepfert H,
Batsakis JG and el-Naggar AK: Genetic alterations in oral squamous
cell carcinoma of young adults. Oral Oncol. 35:251–256. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Regezi JA, Dekker NP, McMillan A,
RamirezAmador V, MenesesGarcia A, Ruiz-Godoy Rivera LM, Chrysomali
E and Ng IO: p53, p21, Rb, and MDM2 proteins in tongue carcinoma
from patients <35 versus >75 years. Oral Oncol. 35:379–383.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Benevenuto TG, Nonaka CF, Pinto LP and de
Souza LB: Immunohistochemical comparative analysis of cell
proliferation and angiogenic index in squamous cell carcinomas of
the tongue between young and older patients. Appl Immunohistochem
Mol Morphol. 20:291–297. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hui AB, Lin A, Xu W, Waldron L,
PerezOrdonez B, Weinreb I, Shi W, Bruce J, Huang SH, O'Sullivan B,
et al: Potentially prognostic miRNAs in HPV-associated
oropharyngeal carcinoma. Clin Cancer Res. 19:2154–2162. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
RicieriBrito JA, Gomes CC, Santos Pimenta
FJ, Barbosa AA, Prado MA, Prado VF, Gomez MV and Gomez RS: Reduced
expression of mir15a in the blood of patients with oral squamous
cell carcinoma is associated with tumor staging. Exp Ther Med.
1:217–221. 2010.PubMed/NCBI
|
|
42
|
Chang CJ, Hsu CC, Chang CH, Tsai LL, Chang
YC, Lu SW, Yu CH, Huang HS, Wang JJ, Tsai CH, et al: Let-7d
functions as novel regulator of epithelial-mesenchymal transition
and chemoresistant property in oral cancer. Oncol Rep.
26:1003–1010. 2011.PubMed/NCBI
|
|
43
|
Maclellan SA, Lawson J, Baik J, Guillaud
M, Poh CF and Garnis C: Differential expression of miRNAs in the
serum of patients with high-risk oral lesions. Cancer Med.
1:268–274. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Jakymiw A, Patel RS, Deming N,
Bhattacharyya I, Shah P, Lamont RJ, Stewart CM, Cohen DM and Chan
EK: Overexpression of dicer as a result of reduced let-7 MicroRNA
levels contributes to increased cell proliferation of oral cancer
cells. Genes Chromosomes Cancer. 49:549–559. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yu CC, Chen YW, Chiou GY, Tsai LL, Huang
PI, Chang CY, Tseng LM, Chiou SH, Yen SH, Chou MY, et al: MicroRNA
let-7a represses chemoresistance and tumorigenicity in head and
neck cancer via stem-like properties ablation. Oral Oncol.
47:202–210. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Christensen BC, Moyer BJ, Avissar M,
Ouellet LG, Plaza SL, McClean MD, Marsit CJ and Kelsey KT: A let-7
microRNA-binding site polymorphism in the KRAS 3′UTR is associated
with reduced survival in oral cancers. Carcinogenesis.
30:1003–1007. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chen Z, Jin Y, Yu D, Wang A, Mahjabeen I,
Wang C, Liu X and Zhou X: Down-regulation of the microRNA-99 family
members in head and neck squamous cell carcinoma. Oral Oncol.
48:686–691. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhang JX, Qian D, Wang FW, Liao DZ, Wei
JH, Tong ZT, Fu J, Huang XX, Liao YJ, Deng HX, et al: MicroRNA-29c
enhances the sensitivities of human nasopharyngeal carcinoma to
cisplatin-based chemotherapy and radiotherapy. Cancer Lett.
329:91–98. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhang X, Huang L, Zhao Y and Tan W:
Downregulation of miR-130a contributes to cisplatin resistance in
ovarian cancer cells by targeting X-linked inhibitor of apoptosis
(XIAP) directly. Acta Biochim Biophys Sin (Shanghai). 45:995–1001.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Dai Y, Xie CH, Neis JP, Fan CY, Vural E
and Spring PM: MicroRNA expression profiles of head and neck
squamous cell carcinoma with docetaxel-induced multidrug
resistance. Head Neck. 33:786–791. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Xu N, Shen C, Luo Y, Xia L, Xue F, Xia Q
and Zhang J: Upregulated miR-130a increases drug resistance by
regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell.
Biochem Biophys Res Commun. 425:468–472. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yang J, Han S, Huang W, Chen T, Liu Y, Pan
S and Li S: A meta-analysis of microRNA expression in liver cancer.
PLoS One. 9:e1145332014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
He L, Wang HY, Zhang L, Huang L, Li JD,
Xiong Y, Zhang MY, Jia WH, Yun JP, Luo RZ and Zheng M: Prognostic
significance of low DICER expression regulated by miR-130a in
cervical cancer. Cell Death Dis. 5:e12052014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Shao C, Yu Y, Yu L, Pei Y, Feng Q, Chu F,
Fang Z and Zhou Y: Amplification and up-regulation of microRNA-30b
in oral squamous cell cancers. Arch Oral Biol. 57:1012–1017. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Reinhart BJ, Slack FJ, Basson M,
Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR and Ruvkun G:
The 21-nucleotide let-7 RNA regulates developmental timing in
Caenorhabditis elegans. Nature. 403:901–906. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Takamizawa J, Konishi H, Yanagizawa K,
Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y,
et al: Reduced expression of the let-7 microRNAs in human lung
cancers in association with shortened postoperative survival.
Cancer Res. 64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Akao Y, Nakagawa Y and Naoe T: Let-7
microRNA functions as a potential growth suppressor in human colon
cancer cells. Biol Pharm Bull. 29:903–906. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Zhang B, Pan X, Cobb GP and Anderson TA:
MicroRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Lu J, Getz G, Miska EA, AlvarezSaavedra E,
Lamb J, Peck D, SweetCordero A, Ebert BL, Mak RH, Ferrando AA, et
al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Johnson SM, Grosshans H, Shingara J, Byrom
M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D and Slack
FJ: RAS is regulated by the let-7 MicroRNA family. Cell.
120:635–647. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Rana TM: Illuminating the silence:
Understanding the structure and function of small RNAs. Nat Rev Mol
Cell Biol. 8:23–36. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Chiosea S, Jelezcova E, Chandran U,
Acquafondata M, McHale T, Sobol RW and Dhir R: Up-regulation of
dicer, a component of the MicroRNA machinery, in prostate
adenocarcinoma. Am J Pathol. 169:1812–1820. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Chiosea S, Jelezcova E, Chandran U, Luo J,
Mantha G, Sobol RW and Dacic S: Overexpression of Dicer in
precursor lesions of lung adenocarcinoma. Cancer Res. 67:2345–2350.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Perez-Ordoñez B, Beauchemin M and Jordan
RC: Molecular biology of squamous cell carcinoma of the head and
neck. J Clin Pathol. 59:445–453. 2006. View Article : Google Scholar : PubMed/NCBI
|
